/ Media

Genentech at ASCO 2012

May 30th, 2012

Genentech to report progress at the American Society of Clinical Oncology

Genentech will present important new data from studies of several cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) from June 1-5, 2012, in Chicago.

This page is intended to be a media resource for Genentech developments at ASCO. It will be updated frequently throughout the meeting.


Related news releases

New Data on Important Progress for People with Advanced Cancers (5/15/2012)

Medicine Reduced Risk of a Difficult-to-Treat Ovarian Cancer From Getting Worse (6/1/2012)

Pivotal Trial of Investigational Breast Cancer Medicine Showed Reduced Risk of Cancer Worsening (6/2/2012)

Metastatic Colorectal Cancer Medicine Helped People Live Longer (6/2/2012)

Fact Sheets

 

Inside the Research: Gene Expressions Video Series


Watch interviews with Genentech scientists to better understand our innovative approach to research.

 

Understanding Biomarkers

Jeff Settleman explains how biomarkers identify which patients may benefit from certain treatments.

The Hedgehog Signaling Pathway and Cancer

Frederic de Sauvage explains the relationship between the Hedgehog signaling pathway and cancer

The RAS-RAF Pathway

Chris Bowden explains the RAS-RAF pathway, an important and evolving area of cancer research.

By The Numbers

30
Oral Presentations at the meeting
3
Studies in the press briefing
2
Medicines in the plenary